BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 32682025)

  • 1. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus.
    Elmariah S; Kim B; Berger T; Chisolm S; Kwatra SG; Mollanazar N; Yosipovitch G
    J Am Acad Dermatol; 2021 Mar; 84(3):747-760. PubMed ID: 32682025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INDIVIDUAL ARTICLE: Management of Prurigo Nodularis.
    Elmariah SB; Tao L; Valdes-Rodriguez R; Laquer V
    J Drugs Dermatol; 2023 Dec; 22(12):SF365502s15-SF365502s22. PubMed ID: 38051855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
    Pereira MP; Basta S; Moore J; Ständer S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2224-2229. PubMed ID: 29869425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
    Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
    Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
    [No Abstract]   [Full Text] [Related]  

  • 5. A critical review of dupilumab for adult patients with prurigo nodularis.
    Biazus Soares G; Yosipovitch G
    Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of prurigo nodularis].
    Zeidler C; Ständer S
    Hautarzt; 2014 Aug; 65(8):709-13. PubMed ID: 25113330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic prurigo.
    Misery L
    Br J Dermatol; 2022 Oct; 187(4):464-471. PubMed ID: 35656799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychosomatic aspects of prurigo nodularis].
    Schneider G; Hockmann J; Stumpf A
    Hautarzt; 2014 Aug; 65(8):704-8. PubMed ID: 25113329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position Statement: Linear prurigo is a subtype of chronic prurigo.
    Pereira MP; Zeidler C; Nau T; Bobko S; Evers AWM; Garcovich S; Gonçalo M; Halvorsen JA; Lambert J; Legat FJ; Leslie T; Metz M; Misery L; Nordlind K; Reich A; Schneider G; Ständer H; Streit M; Szepietowski JC; Wallengren J; Weisshaar E; Ständer S;
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):263-266. PubMed ID: 30288812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and treatment algorithm for chronic nodular prurigo.
    Ständer HF; Elmariah S; Zeidler C; Spellman M; Ständer S
    J Am Acad Dermatol; 2020 Feb; 82(2):460-468. PubMed ID: 31310842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
    Vaidya DC; Schwartz RA
    Acta Dermatovenerol Croat; 2008; 16(1):38-44. PubMed ID: 18358109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Prurigo of Nodular Type: A Review.
    Zeidler C; Tsianakas A; Pereira M; Ständer H; Yosipovitch G; Ständer S
    Acta Derm Venereol; 2018 Feb; 98(2):173-179. PubMed ID: 29135018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab for the Treatment of Prurigo Nodularis.
    Alkhaleefa A; Woo TE; Parsons L
    Skin Therapy Lett; 2023 Nov; 28(6):7-9. PubMed ID: 38016088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INDIVIDUAL ARTICLE: Patient Journey and the Burden of Systemic Comorbidities and Sequalae in Prurigo Nodularis.
    Kwatra SG; Chisolm SS; Puerta Durango KS; Mollanazar NK
    J Drugs Dermatol; 2023 Dec; 22(12):SF365502s12-SF365502s14. PubMed ID: 38051854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the current management and burden of prurigo nodularis in the United States.
    Chisolm SS
    Am J Manag Care; 2023 May; 29(5 Suppl):S63-S72. PubMed ID: 37146288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prurigo nodularis: Epidemiology and clinical features.
    Huang AH; Williams KA; Kwatra SG
    J Am Acad Dermatol; 2020 Dec; 83(6):1559-1565. PubMed ID: 32454098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments.
    Müller S; Zeidler C; Ständer S
    Am J Clin Dermatol; 2024 Jan; 25(1):15-33. PubMed ID: 37717255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab Treatment for Prurigo Nodularis and Pruritis.
    Tanis R; Ferenczi K; Payette M
    J Drugs Dermatol; 2019 Sep; 18(9):940-942. PubMed ID: 31524352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prurigo nodularis: Pathogenesis and management.
    Williams KA; Huang AH; Belzberg M; Kwatra SG
    J Am Acad Dermatol; 2020 Dec; 83(6):1567-1575. PubMed ID: 32461078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
    Yook HJ; Lee JH
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.